CHCHD3 and metabolic dysfunction-associated steatohepatitis: Interestingly, Mic19 LKO mice develop a NASH and liver fibrosis phenotype (Fig. 6), and Mic19 re-expression in Mic19 LKO mice liver remarkably blocks the progression of Mic19 LKO-induced NASH phenotype (Fig. 7).